Amanote Research
Register
Sign In
Immunosuppressive Therapy for Aplastic Anemia in Children: A More Severe Disease Predicts Better Survival
Blood
- United States
doi 10.1182/blood-2005-03-0874
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Immunology
Cell Biology
Hematology
Date
September 15, 2005
Authors
M. Fuhrer
Publisher
American Society of Hematology
Related search
Costs and Consequences of Immunosuppressive Therapy in Children With Aplastic Anemia
Haematologica
Hematology
Predicting Response to Immunosuppressive Therapy in Childhood Aplastic Anemia
Haematologica
Hematology
Allo-HSCT Compared With Immunosuppressive Therapy for Acquired Aplastic Anemia: A System Review and Meta-Analysis
BMC Immunology
Immunology
Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children With Severe Aplastic Anemia Who Lack an HLA-matched Sibling Donor
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Second Allogeneic Hematopoietic Stem Cell Transplantation in Children With Severe Aplastic Anemia
Bone Marrow Transplantation
Transplantation
Hematology
Efficacy and Safety of Immunosuppressive Therapy in the Treatment of Seronegative Hepatitis Associated Aplastic Anemia
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Good Outcome of Haploidentical Hematopoietic SCT as a Salvage Therapy in Children and Adolescents With Acquired Severe Aplastic Anemia
Bone Marrow Transplantation
Transplantation
Hematology
Hematopoietic Growth Factors in Aplastic Anemia Patients Treated With Immunosuppressive Therapy-Systematic Review and Meta-Analysis
Haematologica
Hematology
Severe Aplastic Anemia Associated With Eosinophilic Fasciitis
Medicine
Medicine
